SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-19-000575
Filing Date
2019-02-20
Accepted
2019-02-20 06:07:50
Documents
48
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bkit_10k.htm 10-K 270141
2 CONSULTING AGREEMENT bkit_ex103.htm EX-10.3 2083
3 CERTIFICATION bkit_ex311.htm EX-31.1 9029
4 CERTIFICATION bkit_ex312.htm EX-31.2 8953
5 CERTIFICATION bkit_ex321.htm EX-32.1 3485
12 bkit_10kimg2.jpg GRAPHIC 18016
13 bkit_10kimg3.jpg GRAPHIC 19063
14 bkit_10kimg4.jpg GRAPHIC 6045
15 bkit_ex103img1.jpg GRAPHIC 420387
16 bkit_ex103img2.jpg GRAPHIC 529256
17 bkit_ex103img3.jpg GRAPHIC 273947
  Complete submission text file 0001477932-19-000575.txt   2989590

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bkit-20180831.xml EX-101.INS 153298
7 XBRL TAXONOMY EXTENSION SCHEMA bkit-20180831.xsd EX-101.SCH 17957
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bkit-20180831_cal.xml EX-101.CAL 22869
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkit-20180831_def.xml EX-101.DEF 26376
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkit-20180831_lab.xml EX-101.LAB 100535
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkit-20180831_pre.xml EX-101.PRE 83976
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

IRS No.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-55022 | Film No.: 19617009
SIC: 7200 Services-Personal Services